Omega-3 fatty acids in high-risk cardiovascular patients: A meta-analysis of randomized controlled trials

BMC Cardiovascular Disorders

Volumn 10, Issue , 2010, Pages

  Filion, Kristian B ^a   El Khoury, Fouad ^b   Bielinski, Michael ^a,b   Schiller, Ian ^a   Dendukuri, Nandini ^a,b   Brophy, James M ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAPENTAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; PLACEBO;

ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; DIET SUPPLEMENTATION; DIET THERAPY; DRUG WITHDRAWAL; EMBASE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEDLINE; META ANALYSIS; MORTALITY; PATIENT COMPLIANCE; PATIENT SAFETY; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SYSTEMATIC REVIEW; AGED; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; REVIEW; RISK; SURVIVAL;

AGED; CARDIOVASCULAR DISEASES; CORONARY RESTENOSIS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SURVIVAL ANALYSIS;

EID: 77953012291     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-10-24     Document Type: Article

References (64)

1. Bang HO, Dyerberg J, Hjoorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976, 200:69-73.
2. Bang HO, Dyerberg J. Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med Scand 1972, 192:85-94.
3. Bang HO, Dyerberg J. Lipid metabolism and ischemic heart disease in Greenland Eskimos. Advances in Nutrition Research 1980, 1-22. New York, N.Y.: Plenum Press, Draper H.
4. Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P, Walsh MK, Morris D, Shekelle RB. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997, 336:1046-1053. 10.1056/NEJM199704103361502, 9091800.
5. Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment. BMJ 2004, 328:30-35. 10.1136/bmj.328.7430.30, 313905, 14703544.
6. Dolecek TA, Granditis G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet 1991, 66:205-216.
7. Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, Siscovick DS. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 2003, 107:1372-1377. 10.1161/01.CIR.0000055315.79177.16, 12642356.
8. Mozaffarian D, Ascherio A, Hu FB, Stampfer MJ, Willett WC, Siscovick DS, Rimm EB. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005, 111:157-164. 10.1161/01.CIR.0000152099.87287.83, 1201401, 15630029.
9. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006, 84:5-17.
10. Yuan JM, Ross RK, Gao YT, Yu MC. Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am J Epidemiol 2001, 154:809-816. 10.1093/aje/154.9.809, 11682363.
11. Nettleton JA. Omega-3 fatty acids: comparison of plant and seafood sources in human nutrition. J Am Diet Assoc 1991, 91:331-337.
12. Xiao YF, Sigg DC, Leaf A. The antiarrhythmic effect of n-3 polyunsaturated fatty acids: modulation of cardiac ion channels as a potential mechanism. J Membr Biol 2005, 206:141-154. 10.1007/s00232-005-0786-z, 16456724.
13. Engelbrecht AM, Engelbrecht P, Genade S, Niesler C, Page C, Smuts M, Lochner A. Long-chain polyunsaturated fatty acids protect the heart against ischemia/reperfusion-induced injury via a MAPK dependent pathway. J Mol Cell Cardiol 2005, 39:940-954. 10.1016/j.yjmcc.2005.08.004, 16216266.
14. Harrison N, Abhyankar B. The mechanism of action of omega-3 fatty acids in secondary prevention post-myocardial infarction. Curr Med Res Opin 2005, 21:95-100. 10.1185/030079904X17956, 15881480.
15. Geelen A, Brouwer IA, Zock PL, Katan MB. Antiarrhythmic effects of n-3 fatty acids: evidence from human studies. Curr Opin Lipidol 2004, 15:25-30. 10.1097/00041433-200402000-00006, 15166805.
16. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757. 10.1161/01.CIR.0000038493.65177.94, 12438303.
17. Connor WE. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 2000, 71:171S-175S.
18. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002, 112:298-304. 10.1016/S0002-9343(01)01114-7, 11893369.
19. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV, Durrington PN, Higgins JP, Capps NE, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 2006, 332:752-760. 10.1136/bmj.38755.366331.2F, 1420708, 16565093.
20. Yzebe D, Lievre M. Fish oils in the care of coronary heart disease patients: a meta-analysis of randomized controlled trials. Fundam Clin Pharmacol 2004, 18:581-592. 10.1111/j.1472-8206.2004.00268.x, 15482380.
21. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989, 2:757-761. 10.1016/S0140-6736(89)90828-3, 2571009.
22. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999, 354:1896-1900. 10.1016/S0140-6736(99)04149-5, 10584742.
23. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12. 10.1016/0197-2456(95)00134-4, 8721797.
24. Borchgrevink CF, Skaga E, Berg KJ, Skjaeggestad O. Absence of prophylactic effect of linolenic acid in patients with coronary heart-disease. Lancet 1966, 2:187-189. 10.1016/S0140-6736(66)92474-3, 4161161.
25. Leaf A, Jorgensen MB, Jacobs AK, Cote G, Schoenfeld DA, Scheer J, Weiner BH, Slack JD, Kellett MA, Raizner AE, et al. Do fish oils prevent restenosis after coronary angioplasty?. Circulation 1994, 90:2248-2257.
26. Cairns JA, Gill J, Morton B, Roberts R, Gent M, Hirsh J, Holder D, Finnie K, Marquis JF, Naqvi S, et al. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study. Circulation 1996, 94:1553-1560.
27. Kaul U, Sanghvi S, Bahl VK, Dev V, Wasir HS. Fish oil supplements for prevention of restenosis after coronary angioplasty. Int J Cardiol 1992, 35:87-93. 10.1016/0167-5273(92)90059-C, 1563884.
28. Bellamy CM, Schofield PM, Faragher EB, Ramsdale DR. Can supplementation of diet with omega-3 polyunsaturated fatty acids reduce coronary angioplasty restenosis rate?. Eur Heart J 1992, 13:1626-1631.
29. Grigg LE, Kay TW, Valentine PA, Larkins R, Flower DJ, Manolas EG, O'Dea K, Sinclair AJ, Hopper JL, Hunt D. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol 1989, 13:665-672. 10.1016/0735-1097(89)90609-8, 2537349.
30. Reis GJ, Boucher TM, Sipperly ME, Silverman DI, McCabe CH, Baim DS, Sacks FM, Grossman W, Pasternak RC. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 1989, 2:177-181. 10.1016/S0140-6736(89)90370-X, 2568519.
31. Dehmer GJ, Popma JJ, van den Berg EK, Eichhorn EJ, Prewitt JB, Campbell WB, Jennings L, Willerson JT, Schmitz JM. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 1988, 319:733-740.
32. Milner MR, Gallino RA, Leffingwell A, Pichard AD, Brooks-Robinson S, Rosenberg J, Little T, Lindsay J. Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1989, 64:294-299. 10.1016/0002-9149(89)90522-5, 2526993.
33. Bairati I, Roy L, Meyer F. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 1992, 85:950-956.
34. Franzen D, Schannwell M, Oette K, Hopp HW. A prospective, randomized, and double-blind trial on the effect of fish oil on the incidence of restenosis following PTCA. Cathet Cardiovasc Diagn 1993, 28:301-310. 10.1002/ccd.1810280407, 8462079.
35. Maresta A, Balduccelli M, Varani E, Marzilli M, Galli C, Heiman F, Lavezzari M, Stragliotto E, De Caterina R. Prevention of postcoronary angioplasty restenosis by omega-3 fatty acids: main results of the Esapent for Prevention of Restenosis ITalian Study (ESPRIT). Am Heart J 2002, 143:E5. 10.1067/mhj.2002.121805, 12075272.
36. von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999, 130:554-562.
37. Sacks FM, Stone PH, Gibson CM, Silverman DI, Rosner B, Pasternak RC. Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol 1995, 25:1492-1498. 10.1016/0735-1097(95)00095-L, 7759696.
38. Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med 2002, 21:1601-1623. 10.1002/sim.1189, 12111922.
39. Nye ER, Ablett MB, Robertson MC, Ilsley CD, Sutherland WH. Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty. Aust N Z J Med 1990, 20:549-552.
40. Eritsland J, Arnesen H, Gronseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 1996, 77:31-36. 10.1016/S0002-9149(97)89130-8, 8540453.
41. Rossing P, Hansen BV, Nielsen FS, Myrup B, Holmer G, Parving HH. Fish oil in diabetic nephropathy. Diabetes Care 1996, 19:1214-1219. 10.2337/diacare.19.11.1214, 8908382.
42. Johansen O, Brekke M, Seljeflot I, Abdelnoor M, Arnesen H. N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. J Am Coll Cardiol 1999, 33:1619-1626. 10.1016/S0735-1097(99)00054-6, 10334433.
43. Nilsen DW, Albrektsen G, Landmark K, Moen S, Aarsland T, Woie L. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr 2001, 74:50-56.
44. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105:1897-1903. 10.1161/01.CIR.0000014682.14181.F2, 11997274.
45. Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T, Zotos PC, Haboubi NA, Elwood PC. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 2003, 57:193-200. 10.1038/sj.ejcn.1601539, 12571649.
46. Calo L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E, Meo A, Pandozi C, Staibano M, Santini M. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005, 45:1723-1728. 10.1016/j.jacc.2005.02.079, 15893193.
47. Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, Cox B, Zhang H, Schoenfeld D. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005, 112:2762-2768. 10.1161/CIRCULATIONAHA.105.549527, 16267249.
48. Raitt MH, Connor WE, Morris C, Kron J, Halperin B, Chugh SS, McClelland J, Cook J, MacMurdy K, Swenson R, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 2005, 293:2884-2891. 10.1001/jama.293.23.2884, 15956633.
49. Brouwer IA, Zock PL, Camm AJ, Bocker D, Hauer RN, Wever EF, Dullemeijer C, Ronden JE, Katan MB, Lubinski A, et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 2006, 295:2613-2619. 10.1001/jama.295.22.2613, 16772624.
50. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098. 10.1016/S0140-6736(07)60527-3, 17398308.
51. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival--4. Cardiovasc Drugs Ther 1997, 11:485-491. 10.1023/A:1007757724505, 9310278.
52. Horton R. Expression of concern: Indo-Mediterranean Diet Heart Study. Lancet 2005, 366:354-356. 10.1016/S0140-6736(05)67006-7, 16054927.
53. Mann J. The Indo-Mediterranean diet revisited. Lancet 2005, 366:353-354. 10.1016/S0140-6736(05)67005-5, 16054926.
54. White C. Suspected research fraud: difficulties of getting at the truth. BMJ 2005, 331:281-288. 10.1136/bmj.331.7511.281, 1181273, 16052022.
55. GISSI-HF Investigators Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1223-1230. 10.1016/S0140-6736(08)61239-8, 18757090, GISSI-HF Investigators.
56. Durrington PN, Bhatnagar D, Mackness MI, Morgan J, Julier K, Khan MA, France M. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart 2001, 85:544-548. 10.1136/heart.85.5.544, 1729738, 11303007.
57. Randomized Trial of Omega - 3 Fatty Acids on Top of Modern Therapy after Acute Myocardial Infarction: The OMEGA-Trial. , http://assets.cardiosource.com/OMEGA_Senges.ppt
58. Gerstein H, Yusuf S, Riddle MC, Ryden L, Bosch J. Origin Trial Investigators Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J 2008, 155:26-32. Origin Trial Investigators.
59. ASCEND: A Study of Cardiovascular Events iN Diabetes. , http://www.ctsu.ox.ac.uk/ascend/
60. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Moore H, Worthington HV, Durrington PN, Ness AR, Capps NE, Davey SG, et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev 2004, CD003177.
61. Leon H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 2008, 337:a2931. 10.1136/bmj.a2931, 2612582, 19106137.
62. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: a systematic review. Atherosclerosis 2006, 184:237-246. 10.1016/j.atherosclerosis.2005.06.042, 16084516.
63. Jenkins DJ, Josse AR, Beyene J, Dorian P, Burr ML, LaBelle R, Kendall CW, Cunnane SC. Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis. CMAJ 2008, 178:157-164. 2174988, 18195289.
64. Jenkins DJ, Josse AR, Dorian P, Burr ML, LaBelle TR, Kendall CW, Cunnane SC. Heterogeneity in randomized controlled trials of long chain (fish) omega-3 fatty acids in restenosis, secondary prevention and ventricular arrhythmias. J Am Coll Nutr 2008, 27:367-378.